HPV Testing With 16, 18, and 45 Genotyping Stratifies Cancer Risk for Women With Normal Cytology: Data From the Baseline Phase of the Onclarity Trial

OBJECTIVES: To determine the BD Onclarity human papillomavirus (HPV) assay performance and risk values for cervical intraepithelial neoplasia grade 2 (CIN2) or higher and cervical intraepithelial neoplasia grade 3 (CIN3) or higher during Papanicolaou/HPV cotesting in a negative for intraepithelial l...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoler, Mark H, Wright, Thomas C, Parvu, Valentin, Yanson, Karen, Eckert, Karen, Kodsi, Salma, Cooper, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396747/
https://www.ncbi.nlm.nih.gov/pubmed/30649177
http://dx.doi.org/10.1093/ajcp/aqy169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396747/
https://www.ncbi.nlm.nih.gov/pubmed/30649177
http://dx.doi.org/10.1093/ajcp/aqy169

Ejemplares similares